Search

everythinglearnresearchcommunity

for

Search:↓

Fibrosing alopecia in a pattern distribution is a unique hair loss condition that may respond to antiandrogen therapy.

A woman with an unusual pattern of hair loss was confirmed to have Frontal Fibrosing Alopecia and treated with specific medications.

Scalp biopsies from dermatomyositis patients show chronic hair loss without scarring, with mucin and blood vessel changes being very common.

The document concludes that careful evaluation is key to diagnose and treat women with hair loss, with tests for thyroid, iron, and hormones as needed.

The research found that male pattern hair loss is mostly genetic and involves hair thinning due to hormonal effects and changes in gene expression.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

FAPD and possibly CCCA may be AGA subtypes, and treatments combining antiandrogens, hair growth agents, hair transplants, and anti-inflammatories could be effective.

Mutations in the PADI3 gene are linked to a higher risk of scarring hair loss in women of African descent.

Accurate clinical, histological, and genetic methods are key for understanding and treating hair disorders.

The report found a new type of hair loss in African-American women that affects more areas of the scalp than previously thought.

Polarized microscopy is a quick and free method to correctly identify types of hair loss.

A tick bite caused temporary hair loss in a man, which is a rare condition that usually gets better within 3 months.

Hair loss in African American women, caused by hair care, genetics, and environment, needs more research for better treatment.

Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Different hair loss types need accurate diagnosis for proper treatment.

Triple horizontal scalp biopsies are 98% accurate in diagnosing hair loss, better than single biopsies.

Telogen Effluvium is a common, usually reversible hair loss condition, often improved by removing the trigger and possibly treated with various products, though their effectiveness is uncertain.

CCCA is a hair loss type affecting African women, possibly caused by grooming and chemicals, with various treatments and needing more research.

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Temporal triangular alopecia is a lifelong condition with hairless patches on the side of the head that may be present from birth.

Tight hairstyles and chemical relaxers can cause hair loss known as traction alopecia.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

The document concludes that better treatments for CCCA are needed and more research is required to understand its causes related to hairstyling and genetics.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Detailed history and physical examination are crucial for diagnosing hair loss.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Docetaxel often causes hair loss, with limited effective treatments and no cure for permanent hair loss.